Home Screening of Group B Streptococcus in pregnancy: A systematic review for the laboratory detection
Article Open Access

Screening of Group B Streptococcus in pregnancy: A systematic review for the laboratory detection

  • Valentina Arsić Arsenijević EMAIL logo , Vladimir Gerginić , Biljana Miličić , Aleksandar Jurišić and Ljubomir Petričević
Published/Copyright: August 11, 2025

Abstract

Background

Group B Streptococcus (GBS) is important since almost 1/3 of pregnant women are colonized with GBS, and as much as 50% passes to the newborns, sometimes resulting in severe neonatal infections; that is why there are mandatory guidelines for antepartum screening for GBS vaginal/rectal colonization. Also, bacteria other than GBS and yeasts may affect newborns; therefore, an increase in the current knowledge and improving the guidelines related to the prediction and prevention of neonatal early-onset infections are needed.

Methods

A systematic review was performed to investigate risks, types of specimens, sampling methods, media for GBS recovery, identification tests, gestation week for testing, GBS prevalence, sensitivity, specificity, turnover time for cultures, antigen, and molecular-based tests. A literature search was conducted through the Web of Science, Scopus, and PubMed.

Results

A total of 20 studies were identified with 10,288 patients and 1,334 GBS positive (13%). Eight studies were performed in adequate gestation week and revealed prevalence from 0.2 to 20.8% (conventional tests) and 37 to 45% (molecular tests). In only three studies, vaginal/rectal swab recommended by guidelines was applied.

Conclusions

The heterogeneity of the detection and identification of GBS reduces the scientific and clinical utility of laboratory-based data, and universal antepartum screening with affordable, high-sensitivity traditional tests is needed.

1 Introduction

The vaginal microbiome consists of an ecological community of microorganisms that are important for both maternal and neonatal health. During pregnancy, the vaginal microbiome composition changes, which has a role in ascending infections. For neonates, exposure to the vaginal microbiome during birth or through premature rupture of membranes is an important route for early-onset neonatal infections (EONI). Streptococcus agalactiae, commonly known as Group B Streptococcus (GBS), is a leading cause of EONI. Therefore, carriage investigation among pregnant women by using a screening-based strategy provides the most definitive overarching evidence for clinicians and healthcare staff to prevent the potential harms of GBS infection in newborns timely. While often residing asymptomatically in healthy individuals and can colonize the gastrointestinal and genitourinary tract, in some conditions, GBS might cause urinary tract or skin and soft tissue infections in adults. Up to 1/3 of pregnant women is colonized with GBS (10–40%), and 50% of them may transmit it to the newborn, so adhering to GBS screening guidelines to prevent neonatal infection is important but overall findings demonstrate an averaging low rate of compliance [1]. Severe and life-threatening complications, such as pneumonia, sepsis, or meningitis, are more common in neonates in undeveloped countries, and several guidelines were created with the goal of preventing GBS-related diseases timely [2].

Substantial progress of perinatal GBS screening is done since the first guideline published in 1996, and revised by CDC in 2010 [3]. The stewardship of the guideline was transferred to professional organizations, so The American College of Obstetricians and Gynecology created a recommendations for prophylaxis and treatment of GBS [4], and the American Society for Microbiology created a recommendations for standard laboratory practices related to GBS detection and identification [5]. This universal antepartum GBS screening at 35–37 weeks of gestation, chemoprophylaxis during childbirth, and management of newborns aim to achieve the best neonatal outcomes.

Although much progress has been made, important challenges from a laboratory perspective remain, mainly focusing on proper types of specimens, collection methods, incubation, quantification and identification, and application of molecular, non-culture-based tests for GBS recovery. Deeper insight into molecular tests, their sensitivity, and specificity in routine screening seems important to improve the practice and reduce the rate of GBS neonatal infection, but also to extend it to a symptom-driven approach that groups probable pathogens into one cost-effective and accurate tests in a clinically relevant timeframe.

Although universal screening has been important for the reduction of EONI, some data present that these recommendations are not equally adopted worldwide, and this systematic review aimed to perform the analysis of the current application of the existing guidelines for GBS detection and identification by gathering laboratory data regarding types of specimens, sampling methods, media for GBS recovery, identification tests, gestation week for testing, and GBS prevalence. In addition, sensitivity, specificity and turnover time for culture tests, antigen (Ag) tests, and molecular-nucleic acid amplification tests (NAATs) review, including differential media for GBS recovery by culture, polymerase chain reaction (PCR) for DNA detection, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for accurate GBS identification.

2 Materials and methods

This systematic review of literature was conducted according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [6].

2.1 Search strategy

We aim to identify all types of studies that examined an association between GBS infections in pregnancy, laboratory-based variables, and risk factors for infection and outcomes of pregnancy. Several international and regional databases were searched systematically.

The electronic search was performed in July 2023 in databases: MEDLINE (from 2003 to the present), Web of Science (from 2003 to the present), and Scopus, thus, making a 20-year survey on the published papers. We used the search strategy as a combination of keywords such as controlled vocabulary (MESH – in upper case) and free text terms (in lower case): ((VULVOVAGINITIS) OR (VAGINITIS)) OR (vaginal)) OR (vulvovaginal)) AND ((STREPTOCOCCUS GROUP B) OR (STREPTOCOCCUS AGALACTIAE))) AND ((PREGNANCY) OR (PREGNANT WOMEN))) AND (species)) AND (((prevalence) OR (epidemiology)) OR (rate) OR (guideline)). The PRISMA flowchart synthesizes the screening and selection processes (Figure 1).

Figure 1 
                  GBS and pregnancy – PRISMA flow chart of publication selection for systemic literature review.
Figure 1

GBS and pregnancy – PRISMA flow chart of publication selection for systemic literature review.

PICO (P – patient or population; I – intervention or indicator; C – comparison or control; O – outcome) process was used in evidence-based practice to frame and answer a clinical question in terms of the specific patient’s problem. The conducted systematic review of studies assessed the prevalence of maternal GBS colonization and infections in pregnant women at different gestation weeks (P), with the evaluation of different laboratory tests for GBS detection and determination (I). Screening and treatment for GBS were analyzed in relation to identifying risk factors that may influence the prevalence of GBS, like ethnicity, smoking, and maternal age (C). Clinical outcomes (O) were GBS positivity, analyzed in relation to sampling procedure, identification method, and potential etiologies associated with GBS infection/colonization.

To assure the reliability of the data collected, the electronic search was further supplemented with additional citation searching through the reference lists of identified studies and relevant reviews.

2.2 Eligibility criteria

Original articles that were included in this review were prospective, cross-sectional, or retrospective studies by study design. Studies on animals, in vitro cultures, abstracts, papers in non-English language and articles with inadequate sample or incomplete data were excluded.

2.2.1 Population

Pregnant women in different gestation weeks screened for GBS were included in this study. Only those after the 35th week were discussed.

2.2.2 Types of outcome

The outcome variables evaluated in the included studies were patients’ samples, tests for GBS detection and identification, the gestation week for screening GBS prevalence in pregnancy, predisposing factors, and GBS prevalence.

2.3 Study selection and data extraction

The selection of studies was performed by two authors (V.G. and A.J.) who initially read the titles and abstracts, and then the studies that met the inclusion criteria were considered in full text. Extracted data were collected by two authors (Lj.P. and B.M.) and supervised by the third author (V.A.A.), and included: author, year of publication, country, sample, GBS positivity, tests for GBS detection and identification, type of study, clinical setting, patients’ characteristics and gestation week, as well as predisposing factors.

Based on the PICO question the inclusion criteria can be summarized as (1) Participants/population: pregnant women with informed consent, aged 18 years or older, in all three trimester, and absence of serious organic or systemic diseases (such as coronary heart disease, stroke, and leukemia). (2) Intervention(s): different laboratory tests for GBS detection and determination. (3) Comparator(s)/control: pregnant women without clinical signs and symptoms of GBS infection and without observed risk factors. (4) Study design: human cross-section studies written in English. To ensure that all relevant clinical information, often not tested in experimental studies, was captured, longitudinal observational studies (retrospective and prospective comparative cohort and case–control studies) were also included. (5) Main outcome(s): the primary outcomes of concern were GBS detection.

Based on the PICO question the exclusion criteria can be summarized as (1) papers presenting repeated results or were retracted, reviews, meta-analyses, meeting abstracts, case reports, laboratory or animal studies, editorials, or letters; (2) studies without a direct comparison between groups; and (3) studies published in languages other than English.

2.4 Methodological quality assessment criteria for the evaluation of eligible studies

The Joanna Briggs Institute (JBI) critical appraisal tools (checklist for analytical cross-sectional studies) were used to assess the quality of the included studies and possible risk of bias [7]. This tool consists of eight domains related to clear inclusion criteria, detailed setting description, valid/reliable exposure, objective/standard measurement criteria, confounding factor identification, dealing strategies for confounding factors, valid, reliable outcome measurement, and appropriate statistical analysis. The possible answers for the evaluation were Yes, No, Unclear, or Not/Applicable. Two reviewers (B.M. and V.G.) independently assessed titles and/or abstracts of citations identified against the eligibility criteria and the quality of studies included. In case of disagreement, a third opinion (V.A.A.) was sought.

3 Results

3.1 Study characteristics

The number of studies identified through the selection process was 20 (Figure 1), which examined the occurrence of GBS in pregnant women detected during different procedures or protocols. In geographical terms, data were collected from Europe [811], Asia [1217], North America [18,19], and Africa [2027] (Table 1). The greatest number of patient samples were collected in Japan (n = 1.226) [15] and South Africa (n = 1.404) [23], while the lowest was in Sri Lanka (n = 100) [13] and Tanzania (n = 90) [26]. Study design was not explicitly declared in ten cases (50%). In five cases, the study was prospective, in four cross-sectional and two retrospective (Table 1).

Table 1

Characteristics of included studies by country: predisposing factors, positive GBS findings, sampling type, detection, and identification methods

Country Positive GBS (%) Sampling type Test for detection Type of study Settings Predisposing factors/risks
Year All infections Test for identification Patients
[Ref.] AST Gestation week
Europe
Italy 48/245 (19%)# Vaginal swab Culture BA Retrospective Hospital NA
2021 245/245 AST Premature delivery
[8] 24–36
Italy 265/388 (NA) Vaginal swab Culture Prospective Hospital NA
2012 388 ChromID Strepto B agar All pregnant patients
[9] Surface molecules PCR NA
Multilocus sequence typing (serotype V)
Denmark 117/668 (18%) Vaginal swab Culture BA NA Clinical research unit NA
2014 644/668 Fornix posterior – thigh Healthy pregnant
[10]* 36
France 32/190 (16.8%) Vaginal swab Culture, Columbia BA, Chromogenic StrepBt (BioRad), Medium Granada (bioMérieux), NA NA NA
2009 NA Pregnant women
[11] NA
Asia
India 25/524 (4.8%)# Vaginal swab Culture – aerobic Cross-sectional Hospital Ethnicity previous labors smokers
2010 NA fornix posterior – thigh Pregnant women admitted at term and in preterm labor Gestational age preterm labor
[12] NA
Sri Lanka 18/100 (18%) Vaginal swab introitus vagine (low) Culture Cross-sectional Teaching hospital NA
Conventional
2021 45/100 (45%) Rectal swab Real-time PCR Pregnant women
PCR
[13]* NA >35
China NA Vaginal swab PCR NA Municipal hospital Gestational diabetes mellitus
2022 NA Spontaneous preterm birth and control
[14] First or early second trimester
Japan 154/1226 (12.6%) BA Vaginal swab Culture (Todd-Hewitt broth, BA) NA University hospital pregnant women NA
2015 192/1226 (15.7%) PCR PCR (dltS and cps genes) 36–39
[15]* NA Types Ia, Ib, III
Japan 48/583 (8.2%) Vagina swab Culture (Todd-Hewitt broth, BA) NA Medical Center NA
2003 NA fornix posterior (high) CPS antigens Pregnant women
[16] Types VIII, VI, Ib, III 28
China 190/1391 (13.7%) Vaginal rectal swab Culture (enriched broth media) Prospective General Hospital NA
2023 15/190$ (7.9%) BA, Chrom agar Pregnant women
[17]* NA CAMP test 35–37
VITEK-2, MALDI-TOF MS
North America
Canada 102 Vaginal rectal swab Culture (BA) Prospective Hospital NA
2017 Multilocus sequence typing (serotype III, Ia, V) Healthy pregnant women
[18] PCR
USA 150# Vaginal swab Histone deacetylase NA Hospital NA
2019 Sequences amplified from the V1–V3 region of bacterial ribosomal 16S rRNA genes – PCR First trimester
[19] NA
Africa
Sudan 16/200 (8%) Vaginal swab Cervical swab Microscopy Cross-sectional Hospital NA
2014 176/200 (88%) Culture (BA) Pregnant women
[20] Identification: conventional and biochemical Second and third trimester
Uganda 3/1472 (0.2%)# Vaginal swab Culture: selective media Cross-sectional Health Centre NA
2020 955/1472 Identification: biochemical, VITEK-2 HIV-1 negative pregnant women
[21]* During labor
Egypt 17/310 (5.5%)# Vaginal swab Microscopy NA University Hospital Pregnant with vaginitis NA
2022 211/310 Culture NA
[22] PCR
South Africa 20/1404 (2.8%) Vaginal swab Microscopy Prospective NA HIV does not have an impact on GBS colonization
2011 339/1404 Culture HIV-positive and negative pregnant women
[23]* HIV+ 10/716 During early labor
HIV− 10/688 ≥36
251/716
188/688
Togo 0/302 (0%)# Vaginal swab Microscopy Prospective Hospital NA
2013 221/302 Culture Pregnant women
[24] NA
Lebanon 46/221 (20.8%)# Vaginal swab Culture (BA) NA University Hospital Pregnant women NA
2019 83/221 35–37
[25]*
Tanzania 22/90 (24.4%) Vaginal swab PCR NA NA NA
2022 NA During pregnancy
[26] two times <20 and ≥20
Namibia1 and South Africa2 72/5301 (13.6%1) Vaginal/rectal swab Culture (Todd Hewitt broth, BA) NA Hospital NA
2019 NA scpB gene for capusle types (II, III, V, Ia, IV) Pregnant women
[27]* 37/1002 (37.0%) 35–37 
NA PCR

GBS – group B Streptococcus; BA – blood agar; MALDI-TOF MS – matrix-assisted laser desorption ionization-time of flight mass spectrometry; NA – not applicable; *publications corresponding to the adequate gestation week for screening; AST – antibacterial susceptibility testing; $CAMP negative GBS; #in combination with species, e.g., Candida, Lactobacillus, S. aureus, Enterococcus, E. coli, Mycoplasma, Ureaplasma, Chlamydia, Neisseria, T. vaginalis, K. pneumonia.

3.2 GBS prevalence and applied tests

Out of a total of 10,288 examined patients, 1,334 were found to be positive for GBS, which is around 13% (Table 1). The tests used for GBS detection were mainly conventional (microscopy and culturing) and were done by swabbing the vaginal mucosa. The sample culturing was dominant (17 publications, 85%), but the exact type of culturing media/agar was reported only in eight (40%) publications (Table 1). In certain studies (n = 2), microscopy was paired with cultivation, while in a single publication [22], microscopy was used for GBS detection. In only three studies, PCR was applied [14,19,26], and in five studies, PCR was compared with conventional tests [9,13,15,18,22,27]. Mainly, the GBS identification was done conventionally and in a single study by MALDI-TOF MS [17]. Only eight studies corresponded with the adequate gestation week for screening, showing prevalence from 0.2 to 20.8% (conventional tests) and 37 to 45% (molecular tests).

GBS serotypes were determined in five studies [9,15,16,18,27], and data showed domination of type III [15,16,18,27], followed by type V [9,18,27]. The vaginal microbiota and other infective agents were examined in five studies and revealed different bacteria, mainly Lactobacillus, Staphylococcus aureus, Enterococcus, Escherichia coli, Mycoplasma, Ureaplasma, Chlamydia, Neisseria, Klepsiella pneumoniae, as well as yeast Candida and protozoa Trichomonas vaginalis [8,12,22,24,25].

3.3 Patient samples, risks, and predisposing factors

Different sampling methods were used, such as swabs from vaginal/rectal mucosa, with swabbing being a dominant one. The sample was usually taken from the vaginal mucosa during the control visits to the gynecologist, while rarely included sampling during early labor [23]. Sample collection from pregnant women was done after 35 weeks of pregnancy in seven (33.3%) studies, while in others, either this data was not reported or was done in other periods of pregnancy (Table 1). Only in two studies [8,12] samples were taken from patients undergoing premature labor. Two studies confirmed that GBS colonization is associated with the development of postpartum infections [23] and adverse pregnancy outcomes [27]. In only four studies, vaginal/rectal swabs, recommended by guidelines, were applied [13,17,18,27].

Data regarding risk factors were not shown in 18 studies. Only the study from India [12] revealed predisposing factors such as smoking (4.7%), previous childbirths, gestational age (4.7%), and preterm labor (4.7%). HIV positivity does not have an impact on GBS findings [23].

3.4 Guidelines recommendation and selected studies

A small number of studies [10,13,15,17,23,25,27] could be used for adequate systematic review since only in those studies did the selection criteria follow the guidelines for GBS screening in pregnancy [35]. The selected publications encompassed 7,012 subjects, out of which 604 were GBS positive, representing around 75% of the reported total sample and 50% of all positive GBS (Table 1). These data give the prevalence of GBS around 8.6%. Furthermore, GBS screening method in the selected studies did not give more precise methods than those given for the entire study (previously described).

3.5 Quality assessment of included studies

The quality assessment of included studies is presented in Table 2. Two reviewers independently assessed titles and/or abstracts of citations identified by the eligibility criteria and the quality of studies included. In case of disagreement, a third opinion was sought. Out of 20 included studies, six studies had the maximum number of positive responses according to the score used to assess the quality of studies (Table 2) [10,13,2123,26], two studies had 7 out of 8 positive criteria [12,20], and the remaining 12 studies had 6 out of 8 positive criteria from the quality assessment [8,9,11,14,1618,2427]. The common lack of studies that did not have the maximum number of points refers to the lack of analysis of confounding factors, i.e., lack of analysis of risk factors and determination of risk groups for the existence of GBS infection in pregnant women. Also, the authors excluded potentially confounding groups and performed adequate statistical analysis. Therefore, the overall quality of the evidence for this study was considered “Good.” The absence of this type of analysis is also due to the weakness in the quality of the studies, even in studies with a large number of positive evaluations, since this leads to a lack and weakness of monitored outcomes.

Table 2

Quality assessment of included studies (JBI cross-sectional studies checklist)

Studies Clear inclusion criteria Detailed setting description Valid/reliable exposure Objective/standard measurement criteria Confounding factor identification Dealing strategies for confounding factors Valid reliable outcome measurement Appropriate statistical analysis Quality score
8 Yes Yes Yes Yes No No Yes Yes 6/8
9 Yes Yes Yes Yes No No Yes Yes 6/8
10 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
11 Yes Yes Yes Yes Yes No Yes Yes 6/8
12 Yes Yes Yes Yes Yes No Yes Yes 7/8
13 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
14 Yes Yes Yes Yes Unclear Unclear Yes Yes 6/8
15 Yes Yes Yes Yes No No Yes Yes 6/8
16 Yes Yes Yes Yes No No Yes Yes 6/8
17 Yes Yes Yes Yes No No Yes Yes 6/8
18 Yes Yes Yes Yes No No Yes Yes 6/8
19 Yes Yes Yes Yes No No Yes Yes 6/8
20 Yes Yes Yes Yes Yes No Yes Yes 7/8
21 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
22 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
23 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
24 Yes Yes Yes Yes No No Yes Yes 6/8
25 Yes Yes Yes Yes No No Yes Yes 6/8
26 Yes Yes Yes Yes Yes Yes Yes Yes 8/8
27 Yes Yes Yes Yes No No Yes Yes 6/8

3.6 Sensitivity, specificity, and turnover time for cultures, Ag and molecular (NAATs) based tests used for GBS screening

Non-culture-based tests for GBS detection using Ag detection and molecular-based tests, especially NAATs, have increased in recent years [2834]. Table 3 contains the performance methods, i.e., culture, Ag, and molecular base tests, their sensitivity, specificity, turnaround time, and roughly estimated cost [2834]. Data presented were compared to the culture technique [28,29,31] taken as a golden standard for GBS detection. Ag-based tests were found to be very specific and highly sensitive at a low cost [28,29]; however, in a large number of PRISMA-selected studies (Figure 1) no Ag tests for GBS were found [827]. Molecular-based tests for GBS screening [2834] proved high sensitivity, the possibility to detect small quantities of bacterial DNA or RNA, the short turnover time within hours, and potential to detect polymicrobial pathogens or pathogens that are not easy to recover by culture. However, there are also some disadvantages to these methods: false-positive results, absence of antibiotic susceptibility test results, high cost, and necessity of expensive equipment.

Table 3

GBS detection and the antepartum screening for vaginal–rectal colonization: sensitivity, specificity, and turnover time for cultures, antigens (Ag), and molecular based – NAATs (PCR). Presented data for sensitivity are calculated with culturing taken as the golden standard test

Type of media Sensitivity (%) Specificity (%) Turnaround time (h) Estimated costs Ref.
Culture-based
Culture BA 42.3 100 48–72 Low [28]
Culture BA 81.5 100 24–48 Low [29]
Liquid chromogenic medium 71.1 98.1 24–48 Low [29]
Chromogenic agar plate with pre-enrichment 70.6 91.5 48–72 Low [29]
Culture* 97.7 100 48 Low [30]
Type of test Sensitivity Specificity Turnaround time Cost Ref.
Antigen based
GBS Ag PathoDx 57.3 99.5 Low [28]
GBS Ag (W) 18.5 89.4 0.5–1 Low [29]
GBS Ag (H) 21.7 74.0 0.5–1 Low [29]
GBS Ag (W) with pre-enrichment 76.5 96.6 24–48 Low [29]
Type of test Sensitivity Specificity Turnaround time Cost Ref.
Molecular based – NAATs
PCR scpB 99.6 100 1–2 High [28]
PCR cfb 75.3 100 1–2 High [28]
LAMP 100 94.0 0.5–1 High [29]
LAMP PlusLife® GBS 98.7 92.9 1–2 High [30]
LAMP Ampliflash® GBS 87.4 100.0 1–2 High [30]
qPCR Xpert GBS/CE 62 76 1–2 High [31]
LAMP Ampliflash® GBS 98.1 100 1–2 High [32]
Ct 33 or 40qPCR
qPCR Xpert GBS/CE 95.8 64.5 1–2 High [33]
qPCR Xpert GBS/CE 85.7 95.6 1–2 High [34]

CE – combined enrichment, #LIM broth is a selective medium for the enrichment of GBS from vaginal and rectal samples (Todd-Hewitt broth); BA – blood agar; LAMP – loop-mediated isothermal amplification; *Columbia blood agar plates 5% horse blood (5% CO2) and Granada plates (anaerobic), NAATs – nucleic acid amplification tests.

4 Discussion

From the GBS screening-based perspective, for accurate results, properly addressing gestation week, sample type, and laboratory tests, which have high sensitivity and specificity, are very important, and the collected data in the present study for 17 countries contribute to this pool of knowledge (Table 1). The overall findings demonstrate an averaging low rate of compliance with screening protocol, especially for the type of specimens and gestation age. Despite progress in recommendations for universal GBS screening in pregnancy in the present survey, a low number of publications dealing with this topic in the last 20-year period were detected. A total of 20 studies identified 10,288 examined patients and 1,334 positive for GBS (13%), but only in seven studies did testing correspond with the adequate gestation week for screening [10,13,15,17,23,25,27] (Table 1). Pure adherence to universal screening of pregnant women with vaginal–rectal cultures was described in several publications, and these findings led to recognizing the need to develop improved strategies for optimizing antenatal GBS screening adherence [1]. Data from Greece publish the overall maternal colonization rate of 9.6% and discomfort associated with rectal swabbing [33]. The exact reason for low adherence, discomfort associated with vaginal–rectal sampling, is stressed out in other studies. These data showed that apart from less discomfort, the use of vaginal–perineal samples for assessment of maternal GBS colonization is comparable to the recommended vaginal–rectal swab [34], but the broader application of this modification is not straightforward to know.

The reviewed studies provide evidence that the type of sample is important for the success of GBS screening and accurate prevalence rate. Different samples (e.g., vaginal/rectal, vaginal/perianal, only vaginal, and vaginal/cervical) were used for GBS detection in analyzed studies despite the strict recommendation [5]. In only four studies recommended type of sample (vaginal/rectal) was applied [13,17,18,27] and done correctly starting from the vagina, by entering 2 cm above the introitus, then over the perineum region to the rectum and up to 1 cm into the rectum (Table 1). In this survey, the importance of dual sites testing (vaginal/rectal) was clearly demonstrated only by Mukesi [27], and data reported from Namibia demonstrated a high positive GBS rate if dual colonization is tested (vaginal/rectal; 81.1%) and low rate if only vaginal or only rectal samples are tested (13.5, 5.4%, respectively).

It is important to be aware that the included studies were performed in countries with different economic backgrounds, some of them being undeveloped. This might have influenced different laboratory possibilities since some used traditional tests only (microscopy and culture), while in nine studies, PCR tests (NAATs) were used [9,1315,18,19,22,26,27]. Traditionally, very specific culture tests have been used and recommended for GBS detection, but the application of appropriate high-sensitive molecular tests significantly increases detection results [35]. It is well known that various laboratory tests (e.g., cultivation, Ag tests, NAATs) may yield various results [22], because their sensitivity and specificity may vary. Here, we observed a positive rate from 0.2 to 20.8% for conventional tests and from 37 to 45% for molecular tests. Also, the culture and molecular tests exhibit a great difference in positive rate with values of 18 and 49%, respectively, for the same patients [13]. Some studies revealed that the liquid chromogenic medium has a high specificity (98.1%) and coincidence rate, much higher than chromogenic agar recommended by the CDC (70.6%) [29]. Therefore, to increase the possibility of detecting the causative agent, enriched broth culture is often used in conjunction with traditional agar plate cultures, especially when low levels of GBS are expected in the sample. To overcome this limitation, there is a suggestion to include differential chromogen plates, which are incubated under anaerobic conditions, and data showed that this method increases sensitivity [5]. However, globally, culture-based testing is still predominate due to the cost, laboratory equipment, and test specificity. Thus, this is recommended by the guideline for GBS differentiation as a standard protocol, but in this survey, the suggested method has been rarely used. It is known that culture tests are still the gold standard in microbiological laboratories, especially since they allow accurate microbial identification, susceptibility testing, and serotyping. For the accurate identification a new proteomic method, such as MALDI-TOF MS, is promising [36], but this tool is only available in developed countries. Therefore, only a single study in this survey reported it [17].

Nevertheless, Ag tests or NAATs (PCR) have become more attractive due to short performance time and higher sensitivity. Matter of fact, their laboratory performance and clinical utility are still under investigation, but preliminary data are promising. GBS Ag detection test was found to be more sensitive than the standard tests done by culture. It has a low cost and can be performed in basic diagnostic microbiology services with the potential to replace the standard culture for screening for GBS [28]. The disadvantage of this method is that susceptibility testing is not possible, as well as serotyping or identification of culture. In the field of microbial detection, a significant focus is on NAATs, but when designing the molecular-based detection test, the biological and genetic diversity of GBS, which is relatively large, should be taken into consideration. The literature review showed divergent results regarding GBS screening and test performance. Nevertheless, the evaluation of the analytical performances of NAATs GBS screening is limited and should be highlighted.

Despite screening options and significant progress in early laboratory detection of GBS, EONI including neonatal sepsis is still the third major cause of neonatal deaths resulting in 203,000 deaths per year [37], and the recent data showed that the risk of neonatal sepsis was 5.45 times higher in women who were screened positive when compared to non-GBS carriers [38]. However, it is important to note that other gram-positive bacteria (coagulase-negative Staphylococcus, S. aureus, Streptococcus pneumonia, Enterococcus), gram-negative bacteria (E. coli, Klebsiella pneumoniae, Acinetobacter baumannii), and some yeasts (e.g., Candida) are emerging neonatal sepsis pathogens [2,37], so with the present survey it is highlighted that several studies demonstrated vaginal colonization with microbes other than GBS (Table 1). Despite the fact that high adherence to GBS screening recommendations and using an intepartum NAAT gives highly sensitive results, with the ability to significantly reduce the likelihood of neonatal infections, from the future perspective in the prevention of GBS and EONI in general, new microbiological tests, new clinical prediction models and risks estimation, and new monitoring strategies seems crucial [39]. From a laboratory perspective, this primarily means including point-of-care tests, multiplex specific PCR tests, and tests combining differential agar for polymicrobial detection for screening vaginal colonization during pregnancy are able to detect all pathogens which may be potentially involved in EONI [29,30,40]. Following these recommendations and steps, our study group has organized an interactive platform for “prediction, prevention, and personalization in microbiology” in order to reduce the likelihood of neonatal infection or development of EONI, and ongoing studies based on professional and patient education and participation in the diagnosis of selected infections in pregnancy and implementation of novel platform have been designed.

  1. Funding information: This work was funded by Science Fund of the Republic of Serbia – Serbian Science and Diaspora Collaboration Program Knowledge Exchange Vouchers “Combined Chrom agar Candida spp. and Streptococcus agalactiae test for screening vaginal colonization in pregnant women” (CCA-CSAT-SVCPW – No 6466878) and by Science Fund of the Republic of Serbia Program Ideas “Prediction, prevention and patient’s participation in diagnosis of selected fungal infections – FI: an implementation of novel method for obtaining tissue specimens” (FungalCaseFinder – No: 7754282).

  2. Author contributions: Conceptualization, V.A.A. and Lj.P.; methodology, V.G. and A.J.; software, B.M.; validation, B.M.; investigation, V.G. and B.M.; resources, V.A.A.; data curation, B.M.; writing original draft preparation, V.G.; writing review and editing, V.A.A.; visualization, V.G.; supervision, V.A.A. and Lj.P.; project administration, V.G.; funding acquisition, V.A.A. All authors have read and agreed to the published version of the manuscript.

  3. Conflict of interest: The authors declare no conflicts of interest.

  4. Data availability statement: All data generated or analyzed during this study are included in this published article and its supplementary information files.

References

[1] Pangerl S, Sundin D, Geraghty S. Group B Streptococcus screening guidelines in pregnancy: a critical review of compliance. Matern Child Health J. 2021 Feb;25(2):257–67. 10.1007/s10995-020-03113-z. Epub 2021 Jan 4. PMID: 33394277.Search in Google Scholar PubMed

[2] Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early onset neonatal sepsis. Clin Microbiol Rev. 2014;27:21–47. 10.1128/CMR.00031-13.Search in Google Scholar PubMed PubMed Central

[3] Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.Search in Google Scholar

[4] Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion summary, number 782. Obstet Gynecol. 2019;134(1):1. 10.1097/AOG.0000000000003335.Search in Google Scholar PubMed

[5] Filkins L, Hauser JR, Robinson-Dunn B, Tibbetts R, Boyanton BL, Revell P. American society for microbiology provides 2020 guidelines for detection and identification of group B Streptococcus. J Clin Microbiol. 2020;59(1):e01230–20. 10.1128/JCM.01230-20.Search in Google Scholar PubMed PubMed Central

[6] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. 10.1136/bmj.n71.Search in Google Scholar PubMed PubMed Central

[7] Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI manual for evidence synthesis. London, UK: JBI; 2020.10.46658/JBIRM-17-06Search in Google Scholar

[8] Arena B, Daccò MD. Evaluation of vaginal microbiota in women admitted to the hospital for premature labor. Acta Biomed. 2021;92(5):e2021292. 10.23750/abm.v92i5.9925.Search in Google Scholar PubMed PubMed Central

[9] De Francesco MA, Caracciolo S, Gargiulo F, Manca N. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy. Eur J Clin Microbiol Infect Dis. 2012;31(8):1741–7. 10.1007/s10096-011-1495-4.Search in Google Scholar PubMed

[10] Stokholm J, Schjørring S, Eskildsen CE, Pedersen L, Bischoff AL, Følsgaard N, et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect. 2014;20(7):629–35. 10.1111/1469-0691.12411.Search in Google Scholar PubMed

[11] Tazi A, Doloy A, Réglier-Poupet H, Hemet ME, Raymond J, Poyart C. Evaluation du nouveau milieu chromogène StrepB Select pour le dépistage anténatal des streptocoques du groupe B chez la femme enceinte [Evaluation of the new chromogenic medium StrepB Select for screening of group B Streptococcus in pregnant women]. Pathol Biol (Paris). 2009;57(3):225–8. 10.1016/j.patbio.2008.09.002.Search in Google Scholar PubMed

[12] Dechen TC, Sumit K, Ranabir P. Correlates of vaginal colonization with group B Streptococci among pregnant women. J Glob Infect Dis. 2010;2(3):236–41. 10.4103/0974-777X.68536.Search in Google Scholar PubMed PubMed Central

[13] Dilrukshi GN, Kottahachchi J, Dissanayake DMBT, Pathiraja RP, Karunasingha J, Sampath MKA, et al. Group B streptococcus colonization and their antimicrobial susceptibility among pregnant women attending antenatal clinics in tertiary care hospitals in the Western Province of Sri Lanka. J Obstet Gynaecol. 2021;41(1):1–6. 10.1080/01443615.2020.1716313.Search in Google Scholar PubMed

[14] Kan H, He Y, Li Q, Mu Y, Dong Y, Fan W, et al. Differential effect of vaginal microbiota on spontaneous preterm birth among Chinese pregnant women. Biomed Res Int. 2022;2022:3536108. 10.1155/2022/3536108.Search in Google Scholar PubMed PubMed Central

[15] Morozumi M, Chiba N, Igarashi Y, Mitsuhashi N, Wajima T, Iwata S, et al. Direct identification of Streptococcus agalactiae and capsular type by real-time PCR in vaginal swabs from pregnant women. J Infect Chemother. 2015;21(1):34–8. 10.1016/j.jiac.2014.08.024.Search in Google Scholar PubMed

[16] Matsubara K, Katayama K, Baba K, Nigami H, Harigaya H. Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan. Eur J Clin Microbiol Infect Dis. 2003;22(7):453–4. 10.1007/s10096-003-0942-2.Search in Google Scholar PubMed

[17] Zhou J, Zhang L, Zhang Y, Liu H, Xu K, Zhang B, et al. Analysis of molecular characteristics of CAMP-negative Streptococcus agalactiae strains. Front Microbiol. 2023;14:1189093. 10.3389/fmicb.2023.1189093.Search in Google Scholar PubMed PubMed Central

[18] Teatero S, Ferrieri P, Martin I, Demczuk W, McGeer A, Fittipaldi N. Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women. J Clin Microbiol. 2017;55(2):412–22. 10.1128/JCM.01615-16.Search in Google Scholar PubMed PubMed Central

[19] Witkin SS, Nasioudis D, Leizer J, Minis E, Boester A, Forney LJ. Epigenetics and the vaginal microbiome: influence of the microbiota on the histone deacetylase level in vaginal epithelial cells from pregnant women. Minerva Ginecol. 2019;71(2):171–5. 10.23736/S0026-4784.18.04322-8.Search in Google Scholar PubMed

[20] Abdelaziz ZA, Ibrahim ME, Bilal NE, Hamid ME. Vaginal infections among pregnant women at Omdurman Maternity Hospital in Khartoum, Sudan. J Infect Dev Ctries. 2014;8(4):490–7. 10.3855/jidc.3197.Search in Google Scholar PubMed

[21] Tumuhamye J, Steinsland H, Tumwine JK, Namugga O, Mukunya D, Bwanga F, et al. Vaginal colonisation of women in labour with potentially pathogenic bacteria: a cross-sectional study at three primary health care facilities in Central Uganda. BMC Infect Dis. 2020;20(1):98. 10.1186/s12879-020-4821-6.Search in Google Scholar PubMed PubMed Central

[22] Shawaky SM, Al Shammari MMA, Sewelliam MS, Ghazal AAER, Amer AN. A study on vaginitis among pregnant and non-pregnant females in Alexandria, Egypt: an unexpected high rate of mixed vaginal infection. AIMS Microbiol. 2022;8(2):167–77. 10.3934/microbiol.2022014.Search in Google Scholar PubMed PubMed Central

[23] Sebitloane HM, Moodley J, Esterhuizen TM. Pathogenic lower genital tract organisms in HIV-infected and uninfected women, and their association with postpartum infectious morbidity. S Afr Med J. 2011;101(7):466–9.Search in Google Scholar

[24] Tchelougou D, Karou DS, Kpotsra A, Balaka A, Assih M, Bamoke M, et al. Infections vaginales chez les femmes enceintes au centre hospitalier régional de Sokodé (Togo) entre 2010 et 2011 [Vaginal infections in pregnant women at the Regional Hospital of Sokode (Togo) in 2010 and 2011]. Med Sante Trop. 2013;23(1):49–54. 10.1684/mst.2013.0142.Search in Google Scholar PubMed

[25] Ghaddar N, El Roz A, Ghssein G, Ibrahim JN. Emergence of vulvovaginal candidiasis among lebanese pregnant women: prevalence, risk factors, and species distribution. Infect Dis Obstet Gynecol. 2019;2019:5016810. 10.1155/2019/5016810.Search in Google Scholar PubMed PubMed Central

[26] Juliana NCA, Deb S, Juma MH, Poort L, Budding AE, Mbarouk A, et al. The vaginal microbiota composition and genital infections during and after pregnancy among women in Pemba Island, Tanzania. Microorganisms. 2022;10(3):509. 10.3390/microorganisms10030509.Search in Google Scholar PubMed PubMed Central

[27] Mukesi M, Iweriebor BC, Obi LC, Nwodo UU, Moyo SR, Okoh AI. Prevalence and capsular type distribution of Streptococcus agalactiae isolated from pregnant women in Namibia and South Africa. BMC Infect Dis. 2019;19(1):179. 10.1186/s12879-019-3809-6.Search in Google Scholar PubMed PubMed Central

[28] Rallu F, Barriga P, Scrivo C, Martel-Laferrière V, Laferrière C. Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women. J Clin Microbiol. 2006 Mar;44(3):725–8. 10.1128/JCM.44.3.725-728.2006. PMID: 16517846; PMCID: PMC1393163.Search in Google Scholar PubMed PubMed Central

[29] Gao K, Deng Q, Huang L, Chang CY, Zhong H, Xie Y, et al. Diagnostic performance of various methodologies for group B streptococcus screening in pregnant woman in China. Front Cell Infect Microbiol. 2021 May;11:651968. 10.3389/fcimb.2021.651968. PMI D: 34109134; PMCID: PMC8183470.Search in Google Scholar PubMed PubMed Central

[30] Charfi R, Guyonnet C, Untrau M, Giacometti G, Paper T, Poyart C, et al. Performances of two rapid LAMP-based techniques for the intrapartum detection of Group B Streptococcus vaginal colonization. Ann Clin Microbiol Antimicrob. 2024;23:37. 10.1186/s12941-024-00695-2.Search in Google Scholar PubMed PubMed Central

[31] Vieira LL, Perez AV, Machado MM, Kayser ML, Vettori DV, Alegretti AP, et al. Group B streptococcus detection in pregnant women: comparison of qPCR assay, culture, and the Xpert GBS rapid test. BMC Pregnancy Childbirth. 2019;19(1):532.10.1186/s12884-019-2681-0Search in Google Scholar PubMed PubMed Central

[32] Tonen-Wolyec Serge S, Otuli NL, Otsatre-Okuti M, Atenyi-Kasemire R, Dupont R, Bélec L. Analytical performances of a point-of-care loop-mediated isothermal amplification assay to detect Group B streptococcus in intrapartum pregnant women living in the Democratic Republic of the Congo. Int J Infect Dis. 2024 May;142:106972. 10.1016/j.ijid.2024.02.015. Epub 2024 Feb 20. PMID: 38387704.Search in Google Scholar PubMed

[33] Berikopoulou MM, Pana A, Liakopoulou-Tsitsipi T, Vlahos NF, Papaevangelou V, Soldatou A. Poor adherence to the screening-based strategy of group B streptococcus despite colonization of pregnant women in Greece. Pathogens. 2021 Apr;10(4):418. 10.3390/pathogens10040418. PMID: 33915970; PMCID: PMC8067163.Search in Google Scholar PubMed PubMed Central

[34] Nadeau HCG, Bisson C, Chen X, Zhao YD, Williams M, Edwards RK. Vaginal–perianal or vaginal–perineal compared with vaginal–rectal culture-based screening for Group B Streptococci (GBS) colonization during the third trimester of pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2022 Mar;22(1):204. 10.1186/s12884-022-04546-w. PMID: 35287615; PMCID: PMC8919537.Search in Google Scholar PubMed PubMed Central

[35] Bogiel T, Depka D, Zalas-Więcek P, Rzepka M, Kruszyńska E, Gospodarek-Komkowska E. Application of the appropriate molecular biology-based method significantly increases the sensitivity of group B streptococcus detection results. J Hosp Infect. 2021 Jun;112:21–6. 10.1016/j.jhin.2021.03.008. Epub 2021 Mar 16. PMID: 33741491.Search in Google Scholar PubMed

[36] Tanno D, Saito K, Ohashi K, Toyokawa M, Yamadera Y, Shimura H. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry with time-of-flight peak analysis for rapid and accurate detection of group B streptococcus in pregnant women. Microbiol Spectr. 2022 Jun;10(3):e0173221. 10.1128/spectrum.01732-21. Epub 2022 Apr 18. PMID: 35435738; PMCID: PMC9241660.Search in Google Scholar PubMed PubMed Central

[37] Attia Hussein Mahmoud H, Parekh R, Dhandibhotla S, Sai T, Pradhan A, Alugula S, et al. Insight into neonatal sepsis: an overview. Cureus. 2023 Sep;15(9):e45530. 10.7759/cureus.45530. PMID: 37868444; PMCID: PMC10585949.Search in Google Scholar PubMed PubMed Central

[38] Fung TY, Sahota DS. How can we reduce neonatal sepsis after universal group B streptococcus screening? BMC Pregnancy Childbirth. 2024 Sep;24(1):586. 10.1186/s12884-024-06791-7. PMID: 39244582; PMCID: PMC11380416.Search in Google Scholar PubMed PubMed Central

[39] Kosmeri C, Giapros V, Serbis A, Baltogianni M. Application of advanced molecular methods to study early-onset neonatal sepsis. Int J Mol Sci. 2024 Feb;25(4):2258. 10.3390/ijms25042258. PMID: 38396935; PMCID: PMC10889541.Search in Google Scholar PubMed PubMed Central

[40] Oeser C, Pond M, Butcher P, Bedford Russell A, Henneke P, Laing K, et al. PCR for the detection of pathogens in neonatal early onset sepsis. PLoS One. 2020 Jan;15(1):e0226817. 10.1371/journal.pone.0226817. PMID: 31978082; PMCID: PMC6980546.Search in Google Scholar PubMed PubMed Central

Received: 2024-09-12
Revised: 2025-01-12
Accepted: 2025-04-14
Published Online: 2025-08-11

© 2025 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
  3. Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study
  4. Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway
  5. Risk factors for severe adverse drug reactions in hospitalized patients
  6. Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing
  7. Development and validation of headspace gas chromatography with a flame ionization detector method for the determination of ethanol in the vitreous humor
  8. CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis
  9. Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia
  10. Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
  11. Comparison of the effectiveness of nurse-led preoperative counseling and postoperative follow-up care vs standard care for patients with gastric cancer
  12. Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis
  13. Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
  14. Association between statin administration and outcome in patients with sepsis: A retrospective study
  15. Exploration of the association between estimated glucose disposal rate and osteoarthritis in middle-aged and older adults: An analysis of NHANES data from 2011 to 2018
  16. A comparative analysis of the binary and multiclass classified chest X-ray images of pneumonia and COVID-19 with ML and DL models
  17. Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function
  18. Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
  19. Serum PM20D1 levels are associated with nutritional status and inflammatory factors in gastric cancer patients undergoing early enteral nutrition
  20. Hydromorphone reduced the incidence of emergence agitation after adenotonsillectomy in children with obstructive sleep apnea: A randomized, double-blind study
  21. Vitamin D replacement therapy may regulate sleep habits in patients with restless leg syndrome
  22. The first-line antihypertensive nitrendipine potentiated the therapeutic effect of oxaliplatin by downregulating CACNA1D in colorectal cancer
  23. Health literacy and health-related quality of life: The mediating role of irrational happiness
  24. Modulatory effects of Lycium barbarum polysaccharide on bone cell dynamics in osteoporosis
  25. Mechanism research on inhibition of gastric cancer in vitro by the extract of Pinellia ternata based on network pharmacology and cellular metabolomics
  26. Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study
  27. Clinical analysis of ten cases of HIV infection combined with acute leukemia
  28. Investigating the cardioprotective potential of quercetin against tacrolimus-induced cardiotoxicity in Wistar rats: A mechanistic insights
  29. Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis
  30. Diagnostic value of ratio of blood inflammation to coagulation markers in periprosthetic joint infection
  31. Sex-specific associations of sex hormone binding globulin and risk of bladder cancer
  32. Core muscle strength and stability-oriented breathing training reduces inter-recti distance in postpartum women
  33. The ERAS nursing care strategy for patients undergoing transsphenoidal endoscopic pituitary tumor resection: A randomized blinded controlled trial
  34. The serum IL-17A levels in patients with traumatic bowel rupture post-surgery and its predictive value for patient prognosis
  35. Impact of Kolb’s experiential learning theory-based nursing on caregiver burden and psychological state of caregivers of dementia patients
  36. Analysis of serum NLR combined with intraoperative margin condition to predict the prognosis of cervical HSIL patients undergoing LEEP surgery
  37. Commiphora gileadensis ameliorate infertility and erectile dysfunction in diabetic male mice
  38. The correlation between epithelial–mesenchymal transition classification and MMP2 expression of circulating tumor cells and prognosis of advanced or metastatic nasopharyngeal carcinoma
  39. Tetrahydropalmatine improves mitochondrial function in vascular smooth muscle cells of atherosclerosis in vitro by inhibiting Ras homolog gene family A/Rho-associated protein kinase-1 signaling pathway
  40. A cross-sectional study: Relationship between serum oxidative stress levels and arteriovenous fistula maturation in maintenance dialysis patients
  41. A comparative analysis of the impact of repeated administration of flavan 3-ol on brown, subcutaneous, and visceral adipose tissue
  42. Identifying early screening factors for depression in middle-aged and older adults: A cohort study
  43. Perform tumor-specific survival analysis for Merkel cell carcinoma patients undergoing surgical resection based on the SEER database by constructing a nomogram chart
  44. Unveiling the role of CXCL10 in pancreatic cancer progression: A novel prognostic indicator
  45. High-dose preoperative intraperitoneal erythropoietin and intravenous methylprednisolone in acute traumatic spinal cord injuries following decompression surgeries
  46. RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation
  47. Impact of peripheral conditioning on reperfusion injury following primary percutaneous coronary intervention in diabetic and non-diabetic STEMI patients
  48. Clinical efficacy of azacitidine in the treatment of middle- and high-risk myelodysplastic syndrome in middle-aged and elderly patients: A retrospective study
  49. The effect of ambulatory blood pressure load on mitral regurgitation in continuous ambulatory peritoneal dialysis patients
  50. Expression and clinical significance of ITGA3 in breast cancer
  51. Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy
  52. rSIG combined with NLR in the prognostic assessment of patients with multiple injuries
  53. Toxic metals and metalloids in collagen supplements of fish and jellyfish origin: Risk assessment for daily intake
  54. Exploring causal relationship between 41 inflammatory cytokines and marginal zone lymphoma: A bidirectional Mendelian randomization study
  55. Gender beliefs and legitimization of dating violence in adolescents
  56. Effect of serum IL-6, CRP, and MMP-9 levels on the efficacy of modified preperitoneal Kugel repair in patients with inguinal hernia
  57. Effect of smoking and smoking cessation on hematological parameters in polycythemic patients
  58. Pathogen surveillance and risk factors for pulmonary infection in patients with lung cancer: A retrospective single-center study
  59. Necroptosis of hippocampal neurons in paclitaxel chemotherapy-induced cognitive impairment mediates microglial activation via TLR4/MyD88 signaling pathway
  60. Celastrol suppresses neovascularization in rat aortic vascular endothelial cells stimulated by inflammatory tenocytes via modulating the NLRP3 pathway
  61. Cord-lamina angle and foraminal diameter as key predictors of C5 palsy after anterior cervical decompression and fusion surgery
  62. GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma
  63. Influencing factors of false lumen thrombosis in type B aortic dissection: A single-center retrospective study
  64. MZB1 regulates the immune microenvironment and inhibits ovarian cancer cell migration
  65. Integrating experimental and network pharmacology to explore the pharmacological mechanisms of Dioscin against glioblastoma
  66. Trends in research on preterm birth in twin pregnancy based on bibliometrics
  67. Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
  68. Single-cell transcriptomic analysis identifies a stress response Schwann cell subtype
  69. Acute pancreatitis risk in the diagnosis and management of inflammatory bowel disease: A critical focus
  70. Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients
  71. Interleukin-37 mediates the anti-oral tumor activity in oral cancer through STAT3
  72. CA199 and CEA expression levels, and minimally invasive postoperative prognosis analysis in esophageal squamous carcinoma patients
  73. Efficacy of a novel drainage catheter in the treatment of CSF leak after posterior spine surgery: A retrospective cohort study
  74. Comprehensive biomedicine assessment of Apteranthes tuberculata extracts: Phytochemical analysis and multifaceted pharmacological evaluation in animal models
  75. Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study
  76. Dopamine attenuates ethanol-induced neuronal apoptosis by stimulating electrical activity in the developing rat retina
  77. Correlation between albumin levels during the third trimester and the risk of postpartum levator ani muscle rupture
  78. Factors associated with maternal attention and distraction during breastfeeding and childcare: A cross-sectional study in the west of Iran
  79. Mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experiments
  80. The law on oncological oblivion in the Italian and European context: How to best uphold the cancer patients’ rights to privacy and self-determination?
  81. The prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and prognostic nutritional index for survival in patients with colorectal cancer
  82. Factors affecting the measurements of peripheral oxygen saturation values in healthy young adults
  83. Comparison and correlations between findings of hysteroscopy and vaginal color Doppler ultrasonography for detection of uterine abnormalities in patients with recurrent implantation failure
  84. The effects of different types of RAGT on balance function in stroke patients with low levels of independent walking in a convalescent rehabilitation hospital
  85. Causal relationship between asthma and ankylosing spondylitis: A bidirectional two-sample univariable and multivariable Mendelian randomization study
  86. Correlations of health literacy with individuals’ understanding and use of medications in Southern Taiwan
  87. Correlation of serum calprotectin with outcome of acute cerebral infarction
  88. Comparison of computed tomography and guided bronchoscopy in the diagnosis of pulmonary nodules: A systematic review and meta-analysis
  89. Curdione protects vascular endothelial cells and atherosclerosis via the regulation of DNMT1-mediated ERBB4 promoter methylation
  90. The identification of novel missense variant in ChAT gene in a patient with gestational diabetes denotes plausible genetic association
  91. Molecular genotyping of multi-system rare blood types in foreign blood donors based on DNA sequencing and its clinical significance
  92. Exploring the role of succinyl carnitine in the association between CD39⁺ CD4⁺ T cell and ulcerative colitis: A Mendelian randomization study
  93. Dexmedetomidine suppresses microglial activation in postoperative cognitive dysfunction via the mmu-miRNA-125/TRAF6 signaling axis
  94. Analysis of serum metabolomics in patients with different types of chronic heart failure
  95. Diagnostic value of hematological parameters in the early diagnosis of acute cholecystitis
  96. Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease
  97. Decrease in CD4 and CD8 lymphocytes are predictors of severe clinical picture and unfavorable outcome of the disease in patients with COVID-19
  98. METTL3 blocked the progression of diabetic retinopathy through m6A-modified SOX2
  99. The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors
  100. Exploring cerebrospinal fluid metabolites, cognitive function, and brain atrophy: Insights from Mendelian randomization
  101. Development and validation of potential molecular subtypes and signatures of ocular sarcoidosis based on autophagy-related gene analysis
  102. Widespread venous thrombosis: Unveiling a complex case of Behçet’s disease with a literature perspective
  103. Uterine fibroid embolization: An analysis of clinical outcomes and impact on patients’ quality of life
  104. Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head
  105. Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
  106. Enhancing chronic back pain management: A comparative study of ultrasound–MRI fusion guidance for paravertebral nerve block
  107. Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
  108. Electroacupuncture-induced reduction of myocardial ischemia–reperfusion injury via FTO-dependent m6A methylation modulation
  109. Hemorrhoids and cardiovascular disease: A bidirectional Mendelian randomization study
  110. Cell-free adipose extract inhibits hypertrophic scar formation through collagen remodeling and antiangiogenesis
  111. HALP score in Demodex blepharitis: A case–control study
  112. Assessment of SOX2 performance as a marker for circulating cancer stem-like cells (CCSCs) identification in advanced breast cancer patients using CytoTrack system
  113. Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study
  114. Comparison of the two intestinal anastomosis methods in pediatric patients
  115. Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer
  116. Endotoxin tolerance inhibits NLRP3 inflammasome activation in macrophages of septic mice by restoring autophagic flux through TRIM26
  117. Lateral transperitoneal laparoscopic adrenalectomy: A single-centre experience of 21 procedures
  118. Petunidin attenuates lipopolysaccharide-induced retinal microglia inflammatory response in diabetic retinopathy by targeting OGT/NF-κB/LCN2 axis
  119. Procalcitonin and C-reactive protein as biomarkers for diagnosing and assessing the severity of acute cholecystitis
  120. Factors determining the number of sessions in successful extracorporeal shock wave lithotripsy patients
  121. Development of a nomogram for predicting cancer-specific survival in patients with renal pelvic cancer following surgery
  122. Inhibition of ATG7 promotes orthodontic tooth movement by regulating the RANKL/OPG ratio under compression force
  123. A machine learning-based prognostic model integrating mRNA stemness index, hypoxia, and glycolysis‑related biomarkers for colorectal cancer
  124. Glutathione attenuates sepsis-associated encephalopathy via dual modulation of NF-κB and PKA/CREB pathways
  125. FAHD1 prevents neuronal ferroptosis by modulating R-loop and the cGAS–STING pathway
  126. Association of placenta weight and morphology with term low birth weight: A case–control study
  127. Investigation of the pathogenic variants induced Sjogren’s syndrome in Turkish population
  128. Nucleotide metabolic abnormalities in post-COVID-19 condition and type 2 diabetes mellitus patients and their association with endocrine dysfunction
  129. TGF-β–Smad2/3 signaling in high-altitude pulmonary hypertension in rats: Role and mechanisms via macrophage M2 polarization
  130. Ultrasound-guided unilateral versus bilateral erector spinae plane block for postoperative analgesia of patients undergoing laparoscopic cholecystectomy
  131. Profiling gut microbiome dynamics in subacute thyroiditis: Implications for pathogenesis, diagnosis, and treatment
  132. Delta neutrophil index, CRP/albumin ratio, procalcitonin, immature granulocytes, and HALP score in acute appendicitis: Best performing biomarker?
  133. Anticancer activity mechanism of novelly synthesized and characterized benzofuran ring-linked 3-nitrophenyl chalcone derivative on colon cancer cells
  134. H2valdien3 arrests the cell cycle and induces apoptosis of gastric cancer
  135. Prognostic relevance of PRSS2 and its immune correlates in papillary thyroid carcinoma
  136. Association of SGLT2 inhibition with psychiatric disorders: A Mendelian randomization study
  137. Motivational interviewing for alcohol use reduction in Thai patients
  138. Luteolin alleviates oxygen-glucose deprivation/reoxygenation-induced neuron injury by regulating NLRP3/IL-1β signaling
  139. Polyphyllin II inhibits thyroid cancer cell growth by simultaneously inhibiting glycolysis and oxidative phosphorylation
  140. Relationship between the expression of copper death promoting factor SLC31A1 in papillary thyroid carcinoma and clinicopathological indicators and prognosis
  141. CSF2 polarized neutrophils and invaded renal cancer cells in vitro influence
  142. Proton pump inhibitors-induced thrombocytopenia: A systematic literature analysis of case reports
  143. The current status and influence factors of research ability among community nurses: A sequential qualitative–quantitative study
  144. OKAIN: A comprehensive oncology knowledge base for the interpretation of clinically actionable alterations
  145. The relationship between serum CA50, CA242, and SAA levels and clinical pathological characteristics and prognosis in patients with pancreatic cancer
  146. Identification and external validation of a prognostic signature based on hypoxia–glycolysis-related genes for kidney renal clear cell carcinoma
  147. Engineered RBC-derived nanovesicles functionalized with tumor-targeting ligands: A comparative study on breast cancer targeting efficiency and biocompatibility
  148. Relationship of resting echocardiography combined with serum micronutrients to the severity of low-gradient severe aortic stenosis
  149. Effect of vibration on pain during subcutaneous heparin injection: A randomized, single-blind, placebo-controlled trial
  150. The diagnostic performance of machine learning-based FFRCT for coronary artery disease: A meta-analysis
  151. Comparing biofeedback device vs diaphragmatic breathing for bloating relief: A randomized controlled trial
  152. Serum uric acid to albumin ratio and C-reactive protein as predictive biomarkers for chronic total occlusion and coronary collateral circulation quality
  153. Multiple organ scoring systems for predicting in-hospital mortality of sepsis patients in the intensive care unit
  154. Single-cell RNA sequencing data analysis of the inner ear in gentamicin-treated mice via intraperitoneal injection
  155. Review Articles
  156. The effects of enhanced external counter-pulsation on post-acute sequelae of COVID-19: A narrative review
  157. Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments
  158. Microscopic changes and gross morphology of placenta in women affected by gestational diabetes mellitus in dietary treatment: A systematic review
  159. Review of mechanisms and frontier applications in IL-17A-induced hypertension
  160. Research progress on the correlation between islet amyloid peptides and type 2 diabetes mellitus
  161. The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis
  162. The application of augmented reality in robotic general surgery: A mini-review
  163. The effect of Greek mountain tea extract and wheat germ extract on peripheral blood flow and eicosanoid metabolism in mammals
  164. Neurogasobiology of migraine: Carbon monoxide, hydrogen sulfide, and nitric oxide as emerging pathophysiological trinacrium relevant to nociception regulation
  165. Plant polyphenols, terpenes, and terpenoids in oral health
  166. Laboratory medicine between technological innovation, rights safeguarding, and patient safety: A bioethical perspective
  167. End-of-life in cancer patients: Medicolegal implications and ethical challenges in Europe
  168. The maternal factors during pregnancy for intrauterine growth retardation: An umbrella review
  169. Intra-abdominal hypertension/abdominal compartment syndrome of pediatric patients in critical care settings
  170. PI3K/Akt pathway and neuroinflammation in sepsis-associated encephalopathy
  171. Screening of Group B Streptococcus in pregnancy: A systematic review for the laboratory detection
  172. Giant borderline ovarian tumours – review of the literature
  173. Leveraging artificial intelligence for collaborative care planning: Innovations and impacts in shared decision-making – A systematic review
  174. Cholera epidemiology analysis through the experience of the 1973 Naples epidemic
  175. Risk factors of frailty/sarcopenia in community older adults: Meta-analysis
  176. Supplement strategies for infertility in overweight women: Evidence and legal insights
  177. Scurvy, a not obsolete disorder: Clinical report in eight young children and literature review
  178. A meta-analysis of the effects of DBS on cognitive function in patients with advanced PD
  179. Protective role of selenium in sepsis: Mechanisms and potential therapeutic strategies
  180. Strategies for hyperkalemia management in dialysis patients: A systematic review
  181. C-reactive protein-to-albumin ratio in peripheral artery disease
  182. Case Reports
  183. Delayed graft function after renal transplantation
  184. Semaglutide treatment for type 2 diabetes in a patient with chronic myeloid leukemia: A case report and review of the literature
  185. Diverse electrophysiological demyelinating features in a late-onset glycogen storage disease type IIIa case
  186. Giant right atrial hemangioma presenting with ascites: A case report
  187. Laser excision of a large granular cell tumor of the vocal cord with subglottic extension: A case report
  188. EsoFLIP-assisted dilation for dysphagia in systemic sclerosis: Highlighting the role of multimodal esophageal evaluation
  189. Molecular hydrogen-rhodiola as an adjuvant therapy for ischemic stroke in internal carotid artery occlusion: A case report
  190. Coronary artery anomalies: A case of the “malignant” left coronary artery and its surgical management
  191. Rapid Communication
  192. Biological properties of valve materials using RGD and EC
  193. A single oral administration of flavanols enhances short-term memory in mice along with increased brain-derived neurotrophic factor
  194. Letter to the Editor
  195. Role of enhanced external counterpulsation in long COVID
  196. Expression of Concern
  197. Expression of concern “A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma”
  198. Expression of concern “Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway”
  199. Expression of concern “circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8”
  200. Corrigendum
  201. Corrigendum to “Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism”
  202. Corrigendum to “Comparing the therapeutic efficacy of endoscopic minimally invasive surgery and traditional surgery for early-stage breast cancer: A meta-analysis”
  203. Corrigendum to “The progress of autoimmune hepatitis research and future challenges”
  204. Retraction
  205. Retraction of “miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway”
  206. Retraction of: “LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424”
  207. Retraction of: “SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways”
  208. Special Issue Advancements in oncology: bridging clinical and experimental research - Part II
  209. Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
  210. Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells
  211. The era of increasing cancer survivorship: Trends in fertility preservation, medico-legal implications, and ethical challenges
  212. Bone scintigraphy and positron emission tomography in the early diagnosis of MRONJ
  213. Meta-analysis of clinical efficacy and safety of immunotherapy combined with chemotherapy in non-small cell lung cancer
  214. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part IV
  215. Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development
  216. Special Issue The evolving saga of RNAs from bench to bedside - Part III
  217. Interaction and verification of ferroptosis-related RNAs Rela and Stat3 in promoting sepsis-associated acute kidney injury
  218. The mRNA MOXD1: Link to oxidative stress and prognostic significance in gastric cancer
  219. Special Issue Exploring the biological mechanism of human diseases based on MultiOmics Technology - Part II
  220. Dynamic changes in lactate-related genes in microglia and their role in immune cell interactions after ischemic stroke
  221. A prognostic model correlated with fatty acid metabolism in Ewing’s sarcoma based on bioinformatics analysis
  222. Red cell distribution width predicts early kidney injury: A NHANES cross-sectional study
  223. Special Issue Diabetes mellitus: pathophysiology, complications & treatment
  224. Nutritional risk assessment and nutritional support in children with congenital diabetes during surgery
  225. Correlation of the differential expressions of RANK, RANKL, and OPG with obesity in the elderly population in Xinjiang
  226. A discussion on the application of fluorescence micro-optical sectioning tomography in the research of cognitive dysfunction in diabetes
  227. A review of brain research on T2DM-related cognitive dysfunction
  228. Metformin and estrogen modulation in LABC with T2DM: A 36-month randomized trial
  229. Special Issue Innovative Biomarker Discovery and Precision Medicine in Cancer Diagnostics
  230. CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms
Downloaded on 25.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2025-1197/html
Scroll to top button